[Congressional Record Volume 168, Number 24 (Monday, February 7, 2022)]
[House]
[Page H998]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




                              {time}  2000
                ANALYZE TREATMENT PROTOCOLS FOR COVID-19

  (Mr. GROTHMAN asked and was given permission to address the House for 
1 minute.)
  Mr. GROTHMAN. Madam Speaker, I would like to address the COVID 
pandemic. A lot of people are kind of bored and tired of hearing about 
it, but with 2,000 lives lost a day, we shouldn't keep our eye off the 
ball.
  It seems to be most of the focus or time spent is on masks, 
government shutdowns, and vaccines. But some doctors in my district 
feel that the treatment, once people get to the hospital, is to blame. 
I hope our special committee looks at the treatment people get in the 
hospital, analyzing remdesivir and its cost of well over $3,000 a day, 
to ivermectin and hydroxychloroquine, together with the shortage of 
monoclonal antibodies.
  Doctors in my district feel tens of thousands, if not hundreds of 
thousands, of lives could be saved if people were given something else 
once they got in the hospital. And just because that may not be as sexy 
or interesting, I think it is something our special subcommittee ought 
to take up and see if they can save some lives. It might take some 
standing up to the pharmaceutical industry.

                          ____________________